Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06585007
What this trial is testing

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerOligoprogressive
Universitaire Ziekenhuizen KU Leuven 246
Early research (Phase 1)Study completedNCT06554639
What this trial is testing

A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 12
Not applicableLooking for participantsNCT00451022
What this trial is testing

Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

Who this might be right for
Prostate CancerLiver CancerBreast Cancer+2 more
National Cancer Institute (NCI) 750
Not applicableStudy completedNCT03615131
What this trial is testing

Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate Cancer

Who this might be right for
Prostate Cancer
Kantonsspital Winterthur KSW 157
Not applicableActive Not RecruitingNCT06126172
What this trial is testing

Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions

Who this might be right for
Prostate Cancer
Chang Gung Memorial Hospital 125
Testing effectiveness (Phase 2)Ended earlyNCT04458311
What this trial is testing

Abiraterone Acetate in Combination With Tildrakizumab

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Institute of Cancer Research, United Kingdom 13
Testing effectiveness (Phase 2)Study completedNCT00085228
What this trial is testing

Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 116
Not applicableStudy completedNCT01985828
What this trial is testing

CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Wake Forest University Health Sciences 83
Large-scale testing (Phase 3)Study completedNCT03085095
What this trial is testing

Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Myovant Sciences GmbH 1,134
Not applicableLooking for participantsNCT06171139
What this trial is testing

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer Metastatic
University of California, San Francisco 80
Not applicableActive Not RecruitingNCT02177292
What this trial is testing

High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)

Who this might be right for
Prostate Cancer
Medical College of Wisconsin 80
Large-scale testing (Phase 3)Looking for participantsNCT06972511
What this trial is testing

Maximal Tumor Eradication for Oligometastatic Prostate Cancer

Who this might be right for
Oligometastatic Prostate Cancer
RenJi Hospital 120
Not applicableStudy completedNCT04583072
What this trial is testing

Stockholm3 Validation Study in a Multi-Ethnic Cohort

Who this might be right for
Prostate Cancer (Diagnosis)
Karolinska Institutet 2,152
Very early researchEnrolling By InvitationNCT07240857
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)
Zhejiang University 18
Not applicableLooking for participantsNCT06652607
What this trial is testing

PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer

Who this might be right for
Prostate CancerMetastatic CancerCastrate Sensitive Prostate Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 152
Testing effectiveness (Phase 2)Looking for participantsNCT07299292
What this trial is testing

Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)

Who this might be right for
Prostate Cancer (Diagnosis)
SMED Clinical Research 60
Large-scale testing (Phase 3)Study completedNCT00423475
What this trial is testing

Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 743
Not applicableActive Not RecruitingNCT06964412
What this trial is testing

The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate Brachytherapy

Who this might be right for
Prostate Cancer
Brigham and Women's Hospital 36
Not applicableStudy completedNCT05764330
What this trial is testing

Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance

Who this might be right for
Prostate Carcinoma
Roswell Park Cancer Institute 20
Not applicableLooking for participantsNCT03914391
What this trial is testing

To Identify Potential New Urine Markers for the Screening of Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 10,000
Next Page